High-density lipoprotein (HDL) nanoparticles were synthesized containing the positron emission tomography (PET) isotope 89 Zr and injected into atherosclerosis-bearing animals. Three animal models of atherosclerosis, mice, rabbits, and pigs, were tested. HDL nanoparticles entered plaque macrophages and monocytes, demonstrating delivery to atherosclerotic plaques in animal arteries as measured by PET molecular imaging.
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SUMMARY
Nanoparticles promise to advance the field of cardiovascular theranostics. However, their sustained and targeted delivery remains an important obstacle. The body synthesizes some "natural" nanoparticles, including high-density lipoprotein (HDL), which may home to the atherosclerotic plaque and promote cholesterol efflux.
In a recent article published in JACC: Cardiovascular Imaging, investigators generated modified, radiolabeled HDL nanoparticles and confirmed they accumulated in atherosclerotic lesions from several different species.
These approaches hold promise for the noninvasive diagnosis of vulnerable plaque and in the stratification of Manuscript received January 24, 2017; accepted January 24, 2017.
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